Cerebral Ischemic Preconditioning: the Road So Far…

Molecular Neurobiology

Volumn 53, Issue 4, 2016, Pages 2579-2593

  Vijayakumar N, Thushara ^a   Sangwan, Amit ^a   Sharma, Bhargy ^a   Majid, Arshad ^b   GK, Rajanikant ^a  

^a NATIONAL INSTITUTE OF TECHNOLOGY CALICUT   (India)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cerebral ischemia; Epigenetics; Genomic reprogramming; Ischemic tolerance; Neuroprotection; Preconditioning

Indexed keywords

ENZYME; GLUTAMIC ACID; NITRIC OXIDE SYNTHASE; RECEPTOR;

ANALYTICAL PARAMETERS; BRAIN ISCHEMIA; EPIGENETICS; GENETIC PARAMETERS; GENOMIC REPROGRAMMING; HUMAN; HYPEROXIC PRECONDITIONING; HYPERTHERMIA; HYPOTHERMIA; HYPOXIC PRECONDITIONING; IMMUNE SYSTEM; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PHARMACOLOGICAL PRECONDITIONING; REGULATORY MECHANISM; REMOTE ISCHEMIC PRECONDITIONING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CLINICAL TRIAL (TOPIC); DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; PATHOLOGY;

ANIMALS; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HUMANS; ISCHEMIC PRECONDITIONING;

EID: 84931067729     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9278-z     Document Type: Review

References (183)

1. Mackay J, Mensah G (2004) The Atlas of Heart Disease and Stroke. Organization, World Health
2. Mendis S, Puska P, Norrving B (2011) Global Atlas on cardiovascular disease prevention and control. Organization, World Health
3. Astrup J, Siesjö BK, Symon L (1981) Thresholds in cerebral ischemia—the ischemic penumbra. Stroke 12:723–5. doi:10.1161/01.STR.12.6.723
4. Bramlett HM, Dietrich WD (2004) Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 24:133–150. doi:10.1097/01.WCB.0000111614.19196.04
5. Iadecola C, Anrather J (2011) Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 14:1363–1368. doi:10.1038/nn.2953
6. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283(9):1145–1150
7. Dirnagl U, Becker K, Meisel A (2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8:398–412. doi:10.1016/S1474-4422(09)70054-7
8. Obrenovitch TP (2008) Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 88:211–247. doi:10.1152/physrev.00039.2006
9. Bickler PE, Donohoe PH (2002) Adaptive responses of vertebrate neurons to hypoxia. J Exp Biol 205:3579–3586
10. Shpargel KB et al (2008) Preconditioning paradigms and pathways in the brain. Cleve Clin J Med 75(Suppl 2):S77–82
11. Durukan A, Tatlisumak T (2010) Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection. Exp Transl Stroke Med 2:2. doi:10.1186/2040-7378-2-2
12. Gidday JM (2006) Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7:437–448. doi:10.1038/nrn1927
13. Della-Morte D et al (2013) Age-related reduction of cerebral ischemic preconditioning: myth or reality? Clin Interv Aging 8:1055–1061. doi:10.2147/CIA.S47462
14. Wang L, Traystman RJ, Murphy SJ (2008) Inhalational anesthetics as preconditioning agents in ischemic brain. Curr Opin Pharmacol 8:104–110. doi:10.1016/j.coph.2007.09.005
15. Raval AP, Dave KR, Pérez-Pinzón MA (2006) Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 26:1141–1147. doi:10.1038/sj.jcbfm.9600262
16. Kapinya KJ et al (2002) Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 33:1889–1898. doi:10.1161/01.STR.0000020092.41820.58
17. Dezfulian C (2013) Clinical Cerebral Preconditioning and Postconditioning. In: Gidday JM, Perez-Pinzon MA, Zhang JH (eds) Innate tolerance in the CNS. Springer, New York, pp 553–566
18. Dahl NA, Balfour WM (1964) Prolonged anoxic survival due to anoxia pre-exposure: brain ATP, lactate, and pyruvate. Am J Physiol 207:452–456
19. Vannucci RC, Duffy TE (1976) Carbohydrate metabolism in fetal and neonatal rat brain during anoxia and recovery. Am J Physiol 230:1269–1275
20. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136. doi:10.1161/01.CIR.74.5.1124
21. Cohen MV, Yang XM, Downey JM (1994) Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 74:998–1004. doi:10.1161/01.RES.74.5.998
22. Schurr A et al (1986) Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res 374(2):244–248. doi:10.1016/0006-8993(86)90418-X
23. Chopp M et al (1989) Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat. Neurology 39:1396–1396. doi:10.1212/WNL.39.10.1396
24. Kitagawa K et al (1990) ‘Ischemic tolerance’ phenomenon found in the brain. Brain Res 528:21–24. doi:10.1016/0006-8993(90)90189-I
25. Gidday JM, Fitzgibbons JC, Shah AR, Park TS (1994) Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 168:221–224. doi:10.1016/0304-3940(94)90455-3
26. Adolph EF (1971) Physiological adaptation to hypoxia in newborn rats. Am J Physiol 221:123–127
27. Schurr A et al (1988) Lactic acidosis and recovery of neuronal function following cerebral hypoxia in vitro. Brain Res 438:311–314. doi:10.1016/0006-8993(88)91354-6
28. Chen J, Graham SH, Zhu RL, Simon RP (1996) Stress proteins and tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab 16:566–77. doi:10.1097/00004647-199607000-00006
29. Glazier SS, O'Rourke DM, Graham DI, Welsh FA (1994) Induction of ischemic tolerance following brief focal ischemia in rat brain. J Cereb Blood Flow Metab 14:545–553. doi:10.1038/jcbfm.1994.68
30. Stenzel-Poore MP et al (2003) Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362:1028–1037. doi:10.1016/S0140-6736(03)14412-1
31. Dhodda VK, Sailor KA, Bowen KK, Vemuganti R (2004) Putative endogenous mediators of preconditioning‐induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 89:73–89. doi:10.1111/j.1471-4159.2004.02316.x
32. Benardete EA, Bergold PJ (2009) Genomic analysis of ischemic preconditioning in adult rat hippocampal slice cultures. Brain Res 1292:107–122. doi:10.1016/j.brainres.2009.07.027
33. Xu H, Lu A, Sharp FR (2011) Regional genome transcriptional response of adult mouse brain to hypoxia. BMC Genomics 12:499. doi:10.1186/1471-2164-12-499
34. Kim E et al (2007) Ischemic preconditioning via epsilon PKC activation requires cyclooxygenase-2 activation in vitro. Neuroscience 145:931–941. doi:10.1016/j.neuroscience.2006.12.063
35. Xu GP et al (2002) Improvement in neuronal survival after ischemic preconditioning in hippocampal slice cultures. Brain Res 952(2):153–158. doi:10.1016/S0006-8993(02)02988-8
36. Raval AP, Bramlett H, Perez-Pinzon MA (2006) Estrogen preconditioning protects the hippocampal CA1 against ischemia. Neuroscience 141:1721–1730. doi:10.1016/j.neuroscience.2006.05.016
37. Egashira Y et al (2012) The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model. Brain Res 1461:87–95. doi:10.1016/j.brainres.2012.04.033
38. Ara J et al (2011) Hypoxic-preconditioning induces neuroprotection against hypoxia–ischemia in newborn piglet brain. Neurobiol Dis 43:473–485. doi:10.1016/j.nbd.2011.04.021
39. Cantagrel S et al (2003) Hypoxic preconditioning reduces apoptosis in a rat model of immature brain hypoxia-ischaemia. Neurosci Lett 347:106–110. doi:10.1016/S0304-3940(03)00525-1
40. Azad P, Haddad GG (2013) Genetic animal models of preconditioning. Transl Stroke Res 4:51–55. doi:10.1007/s12975-012-0218-1
41. Zhang N et al (2007) Neuron-specific phosphorylation of c-Jun N-terminal kinase increased in the brain of hypoxic preconditioned mice. Neurosci Lett 423:219–224. doi:10.1016/j.neulet.2007.07.028
42. Traystman RJ (2003) Animal models of focal and global cerebral ischemia. ILAR J 44(2):85–95
43. Liu C, Chen S, Kamme F, Hu BR (2005) Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia. Neuroscience 134:69–80. doi:10.1016/j.neuroscience.2005.03.036
44. Wu C et al (2001) A forebrain ischemic preconditioning model established in C57Black/Crj6 mice. J Neurosci Methods 107:101–106. doi:10.1016/S0165-0270(01)00356-9
45. Zhang QG et al (2006) Ischemic preconditioning negatively regulates plenty of SH3s–mixed lineage kinase 3–Rac1 complex and c-Jun N-terminal kinase 3 signaling via activation of Akt. Neuroscience 143:431–444. doi:10.1016/j.neuroscience.2006.07.049
46. Geddes JW et al (1996) Permanent focal and transient global cerebral ischemia increase glial and neuronal expression of heme oxygenase-1, but not heme oxygenase-2, protein in rat brain. Neurosci Lett 210:205–208. doi:10.1016/0304-3940(96)12703-8
47. Masada T et al (2001) Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat. J Cereb Blood Flow Metab 21:22–33. doi:10.1097/00004647-200101000-00004
48. Miyashita K et al (1994) Induction of ischaemic tolerance in gerbil hippocampus by pretreatment with focal ischaemia. Neuroreport 6:46–48
49. Mark LP et al (2001) Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR Am J Neuroradiol 22:1813–1824
50. Hazell AS (2007) Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int 50:941–953. doi:10.1016/j.neuint.2007.04.026
51. Paschen W (1996) Glutamate excitotoxicity in transient global cerebral ischemia. Acta Neurobiol Exp (Wars) 56:313–322
52. Watters O, O’Connor JJ (2011) A role for tumor necrosis factor-α in ischemia and ischemic preconditioning. J Neuroinflammation 8:87. doi:10.1186/1742-2094-8-87
53. Navon H, Bromberg Y, Sperling O, Shani E (2012) Neuroprotection by NMDA preconditioning against glutamate cytotoxicity is mediated through activation of ERK 1/2, inactivation of JNK, and by prevention of glutamate-induced CREB inactivation. J Mol Neurosci 46:100–108. doi:10.1007/s12031-011-9532-4
54. Soriano FX et al (2006) Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci 26:4509–4518. doi:10.1523/JNEUROSCI.0455-06.2006
55. Miao B et al (2005) Neuroprotective effects of preconditioning ischemia on ischemic brain injury through down-regulating activation of JNK1/2 via N-methyl-D-aspartate receptor-mediated Akt1 activation. J Biol Chem 280:21693–21699. doi:10.1074/jbc.M500003200
56. Lin CH, Chen PS, Gean PW (2008) Glutamate preconditioning prevents neuronal death induced by combined oxygen–glucose deprivation in cultured cortical neurons. Eur J Pharmacol 589(1-3):85–93. doi:10.1016/j.ejphar.2008.05.047
57. Gong SJ et al (2012) Intermittent hypobaric hypoxia preconditioning induced brain ischemic tolerance by up-regulating glial glutamate transporter-1 in rats. Neurochem Res 37(3):527–537
58. Scorziello A et al (2007) NO‐induced neuroprotection in ischemic preconditioning stimulates mitochondrial Mn‐SOD activity and expression via RAS/ERK1/2 pathway. J Neurochem 103(4):1472–1480
59. Kawahara K et al (2004) Nitric oxide produced during ischemia is toxic but crucial to preconditioning-induced ischemic tolerance of neurons in culture. Neurochem Res 29:797–804. doi:10.1023/B:NERE.0000018853.30131.4d
60. Gidday JM (1999) Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab 19(3):331–340. doi:10.1097/00004647-199903000-00011
61. Centeno JM et al (1999) Nitric oxide is involved in anoxic preconditioning neuroprotection in rat hippocampal slices. Brain Res 836(1-2):62–69. doi:10.1016/S0006-8993(99)01610-8
62. Atochin DN et al (2003) Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases. Stroke 34(5):1299–1303. doi:10.1161/01.STR.0000066870.70976.57
63. Zhao P, Zuo Z (2004) Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase–dependent in neonatal rats. Anesthesiology 101(3):695–703
64. Cho S (2005) Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J Cereb Blood Flow Metab 25(4):493–501. doi:10.1038/sj.jcbfm.9600058
65. Vellimana et al (2011) Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 42(3):776–782. doi:10.1161/STROKEAHA.110.607200
66. Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184:53–68. doi:10.1016/j.jneuroim.2006.11.014
67. Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87:779–789. doi:10.1189/jlb.1109766
68. Stevens SL, Stenzel-Poore MP (2006) Toll-like receptors and tolerance to ischaemic injury in the brain. Biochem Soc Trans 34:1352–1355. doi:10.1042/BST0341352
69. Stevens SL et al (2008) Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab 28:1040–1047. doi:10.1038/sj.jcbfm.9600606
70. Karikó K, Weissman D, Welsh FA (2004) Inhibition of toll-like receptor and cytokine signaling—a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24:1288–1304. doi:10.1097/01.WCB.0000145666.68576.71
71. Pradillo JM et al (2009) Toll‐like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J Neurochem 109:287–294. doi:10.1111/j.1471-4159.2009.05972.x
72. Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP (2009) Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158:1007–1020. doi:10.1016/j.neuroscience.2008.07.067
73. Chen Z et al (2012) Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci 32:11706–11715. doi:10.1523/JNEUROSCI.0730-12.2012
74. Rosenzweig HL et al (2007) Endotoxin preconditioning protects against the cytotoxic effects of TNFα after stroke: a novel role for TNFα in LPS-ischemic tolerance. J Cereb Blood Flow Metab 27:1663–1674. doi:10.1038/sj.jcbfm.9600464
75. Vartanian KB et al (2011) LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J Neuroinflammation 8:140. doi:10.1186/1742-2094-8-140
76. Sakata H et al (2012) Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. Brain 135:3298–3310. doi:10.1093/brain/aws259
77. Ohtsuki T, Ruetzler CA, Tasaki K, Hallenbeck JM (1996) Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J Cereb Blood Flow Metab 16:1137–1142. doi:10.1097/00004647-199611000-00007
78. Spera PA, Ellison JA, Feuerstein GZ, Barone FC (1998) IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251:189–192
79. Nogawa S, Zhang F, Ross ME, Iadecola C (1997) Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17:2746–2755
80. Cheng O et al (2011) Cyclooxygenase-2 mediates hyperbaric oxygen preconditioning in the rat model of transient global cerebral ischemia. Stroke 42:484–490. doi:10.1161/STROKEAHA.110.604421
81. Colangelo V et al (2004) Downregulation of COX-2 and JNK expression after induction of ischemic tolerance in the gerbil brain. Brain Res 1016:195–200. doi:10.1016/j.brainres.2004.05.017
82. Iadecola C et al (2001) Increased susceptibility to ischemic brain injury in cyclooxygenase-1–deficient mice. J Cereb Blood Flow Metab 21:1436–1441. doi:10.1097/00004647-200112000-00008
83. Yung LM et al (2012) Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury. Stroke 43:199–204. doi:10.1161/STROKEAHA.111.626911
84. Wacker BK, Perfater JL, Gidday JM (2012) Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway. J Neurochem 123:954–962. doi:10.1111/jnc.12047
85. Yan W et al (2013) SirT1 mediates hyperbaric oxygen preconditioning-induced ischemic tolerance in rat brain. J Cereb Blood Flow Metab 33:396–406. doi:10.1038/jcbfm.2012.179
86. Thompson JW et al (2013) Epsilon PKC increases brain mitochondrial SIRT1 protein levels via heat shock protein 90 following ischemic preconditioning in rats. PLoS One 8:e75753. doi:10.1371/journal.pone.0075753
87. Zhou AM et al (2004) A short cerebral ischemic preconditioning upregulates adenosine receptors in the hippocampal CA1 region of rats. Neurosci Res 48:397–404. doi:10.1016/j.neures.2003.12.010
88. Shen HY et al (2011) Adenosine kinase determines the degree of brain injury after ischemic stroke in mice. J Cereb Blood Flow Metab 31:1648–1659. doi:10.1038/jcbfm.2011.30
89. Pignataro G et al (2012) NCX1 and NCX3: two new effectors of delayed preconditioning in brain ischemia. Neurobiol Dis 45:616–623. doi:10.1016/j.nbd.2011.10.007
90. Valsecchi V et al (2011) NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning. Stroke 42:754–763. doi:10.1161/STROKEAHA.110.597583
91. Venna VR, Li J, Benashski SE, Tarabishy S, McCullough LD (2012) Preconditioning induces sustained neuroprotection by downregulation of AMPK. Neuroscience 201:280–287. doi:10.1016/j.neuroscience.2011.11.014
92. Chavez JC, Baranova O, Lin J, Pichiule P (2006) The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26:9471–9481. doi:10.1523/JNEUROSCI.2838-06.2006
93. Terasaki Y et al (2010) Activation of NR2A receptors induces ischemic tolerance through CREB signaling. J Cereb Blood Flow Metab 30:1441–1449. doi:10.1038/jcbfm.2010.18
94. Bigdeli MR, Khoshbaten A (2008) In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-α converting enzyme/tumor necrosis factor-α/nuclear factor-κB. Neuroscience 153:671–678. doi:10.1016/j.neuroscience.2008.02.064
95. Sharp FR et al (2004) Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 1:26–35. doi:10.1602/neurorx.1.1.26
96. Ruscher K et al (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22:10291–10301
97. Bernaudin M et al (2002) Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22:393–403. doi:10.1097/00004647-200204000-00003
98. Jones NM, Bergeron M (2001) Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J Cereb Blood Flow Metab 21:1105–1114. doi:10.1097/00004647-200109000-00008
99. Vangeison G, Rempe DA (2009) The Janus-faced effects of hypoxia on astrocyte function. Neuroscientist 15:579–588. doi:10.1177/1073858409332405
100. Zhan L et al (2010) Activation of Akt/FoxO signaling pathway contributes to induction of neuroprotection against transient global cerebral ischemia by hypoxic pre‐conditioning in adult rats. J Neurochem 114:897–908. doi:10.1111/j.1471-4159.2010.06816.x
101. Wang LW, Tu YF, Huang CC, Ho CJ (2012) JNK signaling is the shared pathway linking neuroinflammation, blood–brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the immature brain. J Neuroinflammation 9:175. doi:10.1186/1742-2094-9-175
102. Kapinya K, Penzel R, Sommer C, Kiessling M (2000) Temporary changes of the AP-1 transcription factor binding activity in the gerbil hippocampus after transient global ischemia, and ischemic tolerance induction. Brain Res 872:282–293. doi:10.1016/S0006-8993(00)02503-8
103. Huang CY et al (2001) Overexpression of copper-zinc superoxide dismutase attenuates acute activation of activator protein-1 after transient focal cerebral ischemia in mice. Stroke 32:741–747. doi:10.1161/01.STR.32.3.741
104. Guan J (2013) Bone morphogenetic protein-7 (BMP-7) mediates ischemic preconditioning-induced ischemic tolerance via attenuating apoptosis in rat brain. Biochem Biophys Res Commun 441(3):560–566. doi:10.1016/j.bbrc.2013.10.121
105. Guan J et al (2014) Bone morphogenic protein-7 contributes to cerebral ischemic preconditioning induced-ischemic tolerance by activating p38 mitogen-activated protein kinase signaling pathway. Inflammation 37(4):1289–1296. doi:10.1007/s10753-014-9856-7
106. Lusardi TA et al (2010) Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J Cereb Blood Flow Metab 30:744–756. doi:10.1038/jcbfm.2009.253
107. Vannucci RC, Towfighi J, Vannucci SJ (1998) Hypoxic preconditioning and hypoxic‐ischemic brain damage in the immature rat: pathologic and metabolic correlates. J Neurochem 71:1215–1220. doi:10.1046/j.1471-4159.1998.71031215.x
108. Bickler PE, Buck LT (1998) Adaptations of vertebrate neurons to hypoxia and anoxia: maintaining critical Ca2+ concentrations. J Exp Biol 201(8):1141–1152
109. Li S et al (2013) Hypoxic preconditioning stimulates angiogenesis in ischemic penumbra after acute cerebral infarction. Neural Regen Res 8(31):2895–2903
110. Grabb MC, Choi DW (1999) Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J Neurosci 19(5):1657–1662
111. Bigdeli MR (2011) Neuroprotection caused by hyperoxia preconditioning in animal stroke models. ScientificWorldJournal 11:403–421. doi:10.1100/tsw.2011.23
112. Ostrowski RP et al (2008) The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemia. Neurobiol Dis 29(1):1–13. doi:10.1016/j.nbd.2007.07.020
113. Yan W (2013) SirT1 mediates hyperbaric oxygen preconditioning-induced ischemic tolerance in rat brain. J Cereb Blood Flow Metab 33(3):396–406. doi:10.1038/jcbfm.2012.179
114. Hemmen TM et al (2010) Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L) final results. Stroke 41(10):2265–2270. doi:10.1161/STROKEAHA.110.592295
115. Yenari MA, Hemmen TM (2010) Therapeutic hypothermia for brain ischemia: where have we come and where do we go? Stroke 41(10 Suppl):S72–S74. doi:10.1161/STROKEAHA.110.595371
116. Yunoki M et al (2003) Hypothermic preconditioning induces rapid tolerance to focal ischemic injury in the rat. Exp Neurol 181(2):291–300. doi:10.1016/S0014-4886(03)00056-6
117. Nishio S et al (2000) Ischemic tolerance in the rat neocortex following hypothermic preconditioning. J Neurosurg 93(5):845–851. doi:10.3171/jns.2000.93.5.0845
118. Ikeda T, Xia XY, Xia YX, Ikenoue T (1999) Hyperthermic preconditioning prevents blood–brain barrier disruption produced by hypoxia–ischemia in newborn rat. Brain Res Dev Brain Res 117(1):53–58. doi:10.1016/S0165-3806(99)00097-8
119. Du F et al (2010) Hyperthermic preconditioning protects astrocytes from ischemia/reperfusion injury by up-regulation of HIF-1 alpha expression and binding activity. Biochim Biophys Acta 1802(11):1048–1053. doi:10.1016/j.bbadis.2010.06.013
120. Riepe MW et al (1997) Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: “chemical preconditioning”. J Cereb Blood Flow Metab 17(3):257–264. doi:10.1097/00004647-199703000-00002
121. Kitano H, Kirsch JR, Hurn PD, Murphy SJ (2007) Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 27(6):1108–1128. doi:10.1038/sj.jcbfm.9600410
122. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M (1995) Essential role of adenosine, adenosine Al receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Pharmacology 92(10):4666–4670. doi:10.1073/pnas.92.10.4666
123. Wang H et al (2011) Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects. Front Biosci (Elite Ed) 3:604–615
124. Li L, Zuo Z (2009) Isoflurane preconditioning improves short-term and long-term neurological outcome after focal brain ischemia in adult rats. Neuroscience 164(2):497–506. doi:10.1016/j.neuroscience.2009.08.011
125. Statler KD et al (2006) Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury. Brain Res 1076(1):216–224. doi:10.1016/j.brainres.2005.12.106
126. Adamczyk S et al (2010) Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial KATP channel. Br J Anaesth 104(2):191–200. doi:10.1093/bja/aep365
127. Kitano H, Kirsch JR, Hurn PD, Murphy SJ (2007) Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 27:1108–1128. doi:10.1038/sj.jcbfm.9600410
128. Zheng S, Zuo Z (2004) Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol 65(5):1172–1180. doi:10.1124/mol.65.5.1172
129. Morris KC et al (2011) Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab 31(4):1003–1019. doi:10.1038/jcbfm.2010.229
130. Nunes RR et al (2013) Anesthetics, cerebral protection and preconditioning. Braz J Anesthesiol 63(1):119–138. doi:10.1016/S0034-7094(13)70204-6
131. Zhu H, Sun S, Li H, Xu Y (2006) Cerebral ischemic tolerance induced by 3-nitropropionic acid is associated with increased expression of erythropoietin in rats. J Huazhong Univ Sci Technolog Med Sci 26(4):440–443. doi:10.1007/s11596-006-0416-8
132. Lin HY, Wu CL, Huang CC (2010) The Akt-endothelial nitric oxide synthase pathway in lipopolysaccharide preconditioning-induced hypoxic-ischemic tolerance in the neonatal rat brain. Stroke 41(7):1543–1551. doi:10.1161/STROKEAHA.109.574004
133. Jensen HA et al (2011) Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest. Circulation 123(7):714–721. doi:10.1161/CIRCULATIONAHA.110.986497
134. Moskowitz MA, Waeber C (2011) Remote ischemic preconditioning: making the brain more tolerant, safely and inexpensively. Circulation 123(7):709–711. doi:10.1161/CIRCULATIONAHA.110.009688
135. Wang W et al (2014) Limb ischemic preconditioning attenuates cerebral ischemic injury in rat model. Perfusion 29(3):210–218
136. Ren C, Gao X, Steinberg GK, Zhao H (2008) Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning. Neuroscience 151(4):1099–1103. doi:10.1016/j.neuroscience.2007.11.056
137. Hudetz JA et al (2014) Remote ischemic preconditioning prevents deterioration of short-term postoperative cognitive function after cardiac surgery using cardiopulmonary bypass: results of a Pilot Investigation. J Cardiothorac Vasc Anesth 29(2):382–388
138. Koch S, Katsnelson M, Dong C, Perez-Pinzon M (2011) Remote ischemic limb preconditioning after subarachnoid hemorrhage a phase Ib study of safety and feasibility. Stroke 42(5):1387–1391
139. Kim JH et al (2013) Electroacupuncture preconditioning reduces cerebral ischemic injury via BDNF and SDF-1α in mice. BMC Complement Altern Med 13:22. doi:10.1186/1472-6882-13-22
140. Douen AG (2000) Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebal cortex plasma membranes. J Neurochem 75(2):812–818. doi:10.1046/j.1471-4159.2000.0750812.x
141. Liebelt B et al (2010) Exercise preconditioning reduces neuronal apoptosis in stroke by up-regulating heat shock protein-70 (heat shock protein-72) and extracellular-signal-regulated-kinase 1/2. Neuroscience 166(4):1091–1100. doi:10.1016/j.neuroscience.2009.12.067
142. Thompson JW, Dave KR, Young JI, Perez-Pinzon MA (2013) Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance. Neurotherapeutics 10(4):789–797. doi:10.1007/s13311-013-0202-9
143. Endres M et al (2000) DNA methyltransferase contributes to delayed ischemic brain injury. J Neurosci 20(9):3175–3181
144. Lundberg J, Karimi M, von Gertten C, Holmin S, Ekström TJ, Sandberg-Nordqvist AC (2009) Traumatic brain injury induces relocalization of DNA-methyltransferase 1. Neurosci Lett 457:8–11. doi:10.1016/j.neulet.2009.03.10
145. Markus HS et al (2013) Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke 44(5):1220–1225. doi:10.1161/STROKEAHA.111.000217
146. Langley B, Gensert JM, Beal MF, Ratan RR (2005) Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets CNS Neurol Disord 4(1):41–50. doi:10.2174/1568007053005091
147. Stapels M et al (2010) Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci Signal 3(111):ra15. doi:10.1126/scisignal.2000502
148. Hernández-Jiménez M et al (2013) Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke 44(8):2333–2337. doi:10.1161/STROKEAHA.113.001715
149. Simon RP, Meller R, Zhou A, Henshall D (2012) Can genes modify stroke outcome and by what mechanisms? Stroke 43(1):286–291. doi:10.1161/STROKEAHA.111.622225
150. Kim DH, Sætrom P, Snøve O, Rossi JJ (2008) MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A 105(42):16230–16235. doi:10.1073/pnas.0808830105
151. Lee ST et al (2010) MicroRNAs induced during ischemic preconditioning. Stroke 41(8):1646–1651. doi:10.1161/STROKEAHA.110.579649
152. Lee YJ et al (2009) SUMOylation participates in induction of ischemic tolerance. J Neurochem 109(1):257–267
153. Tu XK et al (2014) Repetitive ischemic preconditioning attenuates inflammatory reaction and brain damage after focal cerebral ischemia in rats: involvement of PI3K/Akt and ERK1/2 signaling pathway. J Mol Neurosci 55(4):912–922. doi:10.1007/s12031-014-0446-9, Epub 2014 Oct 22
154. Jiang T et al (2014) Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagy. Br J Pharmacol 171(13):3146–3157. doi:10.1111/bph.12655
155. Wei L et al (2012) Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis 46(3):635–645
156. Li S et al (2015) Safety and feasibility of remote limb ischemic preconditioning in patients with unilateral middle cerebral artery stenosis and healthy volunteers. Cell Transplant. doi:10.3727/096368914X683520
157. Kokošová N, Danielisova V, Smajda B, Burda J (2014) Ionizing radiation as preconditioning against transient cerebral ischemia in rats. Gen Physiol Biophys 33(4):403–410
158. Rana G et al (2012) Cortical spreading depression differentially affects lysine methylation of H3 histone at neuroprotective genes and retrotransposon sequences. Brain Res 1467:113–119
159. Lee JY, et al (2015) Indomethacin preconditioning induces ischemic tolerance by modifying zinc availability in the brain. Neurobiol Dis (14)00390-8. doi: 10.1016/j.nbd.2014.12.019
160. Keep RF et al (2014) Full steam ahead with remote ischemic conditioning for stroke. Transl Stroke Res 5(5):535–537
161. Lovett JK et al (2003) Very early risk of stroke after a first transient ischemic attack. Stroke 34(8):e138–e140. doi:10.1161/01.STR.0000080935.01264.91
162. Weih M et al (1999) Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke 30(9):1851–1854. doi:10.1161/01.STR.30.9.1851
163. Moncayo J et al (2000) Do transient ischemic attacks have a neuroprotective effect? Neurology 54(11):2089–2094. doi:10.1212/WNL.54.11.2089
164. Wegener et al (2004) Transient ischemic attacks before ischemic stroke: preconditioning the human brain?: a multicenter magnetic resonance imaging study. Stroke 35(3):616–621. doi:10.1161/01.STR.0000115767.17923.6A
165. Sitzer M et al (2004) Transient ischaemic attack preceding anterior circulation infarction is independently associated with favourable outcome. J Neurol Neurosurg Psychiatry 75(4):659–660
166. Schaller B (2005) Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci Lett 377(3):206–211. doi:10.1016/j.neulet.2004.12.004
167. Zsuga J et al (2008) Prior transient ischemic attack is independently associated with lesser in‐hospital case fatality in acute stroke. Psychiatry Clin Neurosci 62(6):705–712. doi:10.1111/j.1440-1819.2008.01874.x
168. Johnston SC (2004) Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study. Stroke 35(11 Suppl 1):2680–2682. doi:10.1161/01.STR.0000143322.20491.0f
169. Hecker JG, McGarvey M (2011) Heat shock proteins as biomarkers for the rapid detection of brain and spinal cord ischemia: a review and comparison to other methods of detection in thoracic aneurysm repair. Cell Stress Chaperones 16(2):119–131. doi:10.1007/s12192-010-0224-8
170. Castillo J et al (2003) The release of tumor necrosis factor–α is associated with ischemic tolerance in human stroke. Ann Neurol 54(6):811–819. doi:10.1002/ana.10765
171. Laudenbach V et al (2007) Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis 26(1):243–252. doi:10.1016/j.nbd.2006.12.020
172. Matsuo R et al (2013) Clinical significance of plasma VEGF value in ischemic stroke- research for biomarkers in ischemic stroke (REBIOS) study. BMC Neurol 13:32. doi:10.1186/1471-2377-13-32
173. Vasdekis SN, Athanasiadis D, Lazaris A et al (2013) The role of remote ischemic preconditioning in the treatment of atherosclerotic diseases. Brain Behav 3(6):606–616. doi:10.1002/brb3.161
174. Meng R et al (2012) Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology 79(18):1853–1861. doi:10.1212/WNL.0b013e318271f76a
175. Gonzalez NR et al (2013) Cerebral hemodynamic and metabolic effects of remote ischemic preconditioning in patients with subarachnoid hemorrhage, Cerebral Vasospasm: Neurovascular Events After Subarachnoid Hemorrhage. Springer, Vienna, pp 193–198
176. Hausenloy DJ et al (2007) Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370(9587):575–579. doi:10.1016/S0140-6736(07)61296-3
177. Thielmann et al (2010) Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol 105(5):657–664. doi:10.1007/s00395-010-0104-5
178. Zuo Z (2012) Are volatile anesthetics neuroprotective or neurotoxic. Med Gas Res 2(1):10
179. Caplan LR (2013) Creating one problem to try and fix another: the saga of ischemic preconditioning. Brain Behav 3(6):603–605. doi:10.1002/brb3.170
180. Schaller B, Graf R (2002) Cerebral ischemic preconditioning. J Neurol 249(11):1503–1511. doi:10.1007/s00415-002-0933-8
181. Mergenthaler P, Dirnagl U (2011) Protective conditioning of the brain: expressway or roadblock? J Physiol 589(17):4147–4155. doi:10.1113/jphysiol.2011.209718
182. Koch S (2010) Preconditioning the human brain: practical considerations for proving cerebral protection. Transl Stroke Res 1(3):161–169. doi:10.1007/s12975-010-0025-5
183. Correia et al (2010) Mitochondrial preconditioning: a potential neuroprotective strategy. Front Aging Neurosci: 138. doi: 10.3389/fnagi.2010.00138